Vetr Upgrades Valeant

By: via Benzinga
The Vetr crowd downgraded Valeant Pharmaceuticals International, Inc. (NASDAQ: VRX) from 4 stars to 4.5 stars. The crowd rates Valeant ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.